A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

De Vita, Salvatore; Quartuccio, Luca; Isola, Miriam; Mazzaro, Cesare; Scaini, Patrizia; Lenzi, Marco; Campanini, M.; Naclerio, Caterina; Tavoni, Antonio; Pietrogrande, Maurizio; Ferri, Clodoveo; Teresa Mascia, Maria; Masolini, Paola; Zabotti, Alen; Maset, M.; Roccatello, Dario; Linda Zignego, Anna; Pioltelli, Pietro; Gabrielli, Armando; Filippini, Davide; Perrella, O.; Migliaresi, S.; Galli, Massimo; Bombardieri, Stefano; Monti, Giuseppe

doi:10.1002/art.34331

Public

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis

Published in Arthritis & Rheumatism • Dec 6, 2011

Authors:

Salvatore De Vita

Luca Quartuccio

Miriam Isola

Abstract

OBJECTIVE: To conduct a long-term, prospective, randomized controlled trial evaluating rituximab (RTX) therapy for severe mixed cryoglobulinemia or cryoglobulinemic vasculitis (CV). METHODS: Fifty-nine patients with CV and related skin ulcers, active glomerulonephritis, or refractory peripheral neur...

Subject

Medicine

Rituximab

Gastroenterology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!